Literature DB >> 33001522

Revision of diagnostic guidelines for Kawasaki disease (6th revised edition).

Tohru Kobayashi1, Mamoru Ayusawa2, Hiroyuki Suzuki3, Jun Abe4, Shuichi Ito5, Taichi Kato6, Masahiro Kamada7, Junko Shiono8, Kenji Suda9, Keiji Tsuchiya10, Tsuneyuki Nakamura11, Yoshikazu Nakamura12, Yuichi Nomura13, Hiromichi Hamada14, Ryuji Fukazawa15, Kenji Furuno16, Hiroyuki Matsuura17, Tomoyo Matsubara18, Masaru Miura19, Kei Takahashi20.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33001522     DOI： 10.1111/ped.14326

Source DB:  PubMed          Journal:  Pediatr Int        ISSN： 1328-8067            Impact factor:   1.524


× No keyword cloud information.
  20 in total

1.  Differences in Sensitivity Between the Japanese and Z Score Criteria for Detecting Coronary Artery Abnormalities Resulting from Kawasaki Disease.

Authors:  Ryusuke Ae; Yoshihide Shibata; Tohru Kobayashi; Koki Kosami; Masanari Kuwabara; Nobuko Makino; Yuri Matsubara; Teppei Sasahara; Hiroya Masuda; Yosikazu Nakamura
Journal:  Pediatr Cardiol       Date:  2022-09-19       Impact factor: 1.838

Review 2.  Corticosteroids for the treatment of Kawasaki disease in children.

Authors:  Jessica Green; Andrew J Wardle; Robert Mr Tulloh
Journal:  Cochrane Database Syst Rev       Date:  2022-05-27

3.  [Pediatric expert consensus on the application of aspirin in Kawasaki disease].

Authors: 
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-06-15

4.  Low-Dose Prednisone Treatment for IVIG-Resistant Kawasaki Disease with Severe Arthritis and Joint Effusion in Two 3-Year-Old Children.

Authors:  Lingling Fan; Huimin Lv; Shujuan Jiang; Daogang Qin
Journal:  Case Rep Pediatr       Date:  2021-04-02

5.  Incidence of Kawasaki disease before and during the COVID-19 pandemic: a retrospective cohort study in Japan.

Authors:  Kyohei Iio; Kousaku Matsubara; Chisato Miyakoshi; Kunitaka Ota; Rika Yamaoka; Junji Eguchi; Osamu Matsumura; Takahiro Okutani; Ikuyo Ueda; Masahiro Nishiyama
Journal:  BMJ Paediatr Open       Date:  2021-04-02

6.  Infliximab treatment for refractory COVID-19-associated multisystem inflammatory syndrome in a Japanese child.

Authors:  Yohei Yamaguchi; Kei Takasawa; Hitoshi Irabu; Kanako Hiratoko; Yosuke Ichigi; Ko Hirata; Yumie Tamura; Miki Murakoshi; Motoi Yamashita; Hisae Nakatani; Masuhiro Shimoda; Taku Ishii; Tomohiro Udagawa; Masaki Shimizu; Hirokazu Kanegane; Tomohiro Morio
Journal:  J Infect Chemother       Date:  2022-01-24       Impact factor: 2.065

Review 7.  Anti-inflammatory Treatment of Kawasaki Disease: Comparison of Current Guidelines and Perspectives.

Authors:  Piotr Buda; Joanna Friedman-Gruszczyńska; Janusz Książyk
Journal:  Front Med (Lausanne)       Date:  2021-11-30

8.  Etiological and pathophysiological enigmas of severe coronavirus disease 2019, multisystem inflammatory syndrome in children, and Kawasaki disease.

Authors:  Jung-Woo Rhim; Jin-Han Kang; Kyung-Yil Lee
Journal:  Clin Exp Pediatr       Date:  2021-11-23

Review 9.  Multisystem inflammatory syndrome in children during the coronavirus disease pandemic of 2019: a review of clinical features and acute phase management.

Authors:  Naohiro Shioji; Kazuyoshi Aoyama; Marina Englesakis; Gail Annich; Jason T Maynes
Journal:  J Anesth       Date:  2021-05-30       Impact factor: 2.078

Review 10.  What Lies Ahead for Young Hearts in the 21st Century - Is It Double Trouble of Acute Rheumatic Fever and Kawasaki Disease in Developing Countries?

Authors:  Aaqib Zaffar Banday; Sanjib Mondal; Prabal Barman; Archan Sil; Rajni Kumrah; Pandiarajan Vignesh; Surjit Singh
Journal:  Front Cardiovasc Med       Date:  2021-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.